期刊文献+

过/降表达miR-20a-5p的骨肉瘤细胞增殖、侵袭能力及Bax、Bcl-2、E2F5蛋白表达观察 被引量:2

Proliferation and invasion of osteosarcoma cells with over-/down-expression of miR-20a-5P and obser⁃vation of Bax,Bcl-2,and E2F5 protein expression
下载PDF
导出
摘要 目的观察miR-20a-5p在骨肉瘤(OS)细胞中的表达变化,探讨miR-20a-5p表达对OS细胞增殖、凋亡及侵袭的影响及其分子机制。方法采用实时荧光定量PCR法检测正常人成骨细胞系hFOB1.19及OS细胞系(U-20S、143B、Saos-2)中的miR-20a-5p表达量。将OS细胞系143B随机分为miR-20a-5p过表达组、miR-20a-5p抑制表达组及阴性对照组,通过Lipofectamine^(TM)3000分别转染miR-20a-5p mimics、miR-20a-5p inhibit及scramble,转染24 h。采用CCK-8法检测三组培养0、24、48、72 h的的光密度值(OD值),流式细胞术检测细胞凋亡率,Transwell小室实验检测侵袭细胞数。在线数据库TargetScan预测结果显示E2F转录因子5(E2F5)存在与miR-20a-5p结合的潜在靶点,荧光素酶报告基因实验证实miR-20a-5p的靶基因为E2F5,采用Westen blotting法检测细胞Bax、Bcl-2、E2F5蛋白表达。结果OS细胞系U-20S、143B、Saos-2中miR-20a-5p相对表达量分别为1.94±0.35、1.05±0.13、0.35±0.06,均明显低于正常人成骨细胞系hFOB1.19中的3.89±0.53(P均<0.05)。随着培养时间的延长,三组OD值均呈升高趋势;培养24、48、72 h,相同培养时间下miR-20a-5p过表达组、阴性对照组、miR-20a-5p抑制表达组OD值依次升高,组间两两比较P均<0.05。miR-20a-5p过表达组、阴性对照组、miR-20a-5p抑制表达组细胞凋亡率、Bax蛋白相对表达量均依次降低,侵袭细胞数、Bcl-2、E2F5蛋白相对表达量均依次升高,组间两两比较P均<0.05。结论miR-20a-5p在OS细胞系中表达下调,过表达miR-20a-5p可抑制OS细胞增殖、侵袭并诱导细胞凋亡,其机制可能与下调E2F5、Bcl-2及上调Bax蛋白表达有关,降表达miR-20a-5p则具有相反的作用。 Objective To observe the expression changes of miR-20a-5p in the osteosarcoma(OS)cells,and to explore the effects of miR-20a-5p expression on the proliferation,apoptosis,and invasion of OS cells and its molecular mechanism.Methods Real-time quantitative PCR was used to detect the expression of miR-20a-5p in the normal human osteoblast cell line hFOB1.19 and OS cell lines(U-20S,143B,and Saos-2).The OS cell line 143B were randomly divided into the miR-20a-5p overexpression group,the miR-20a-5p inhibitory expression group and the negative control group,which were transfected with miR-20a-5p mimics,miR-20a-5p inhibit and scramble by Lipofectamine^(TM)3000 for 24 h,respectively.The optical density value(OD value)of the three groups at 0,24,48,and 72 h of culture was detected by CCK-8 method.The apoptosis rate was detected by flow cytometry.The number of invasive cells was detected by Transwell chamber assay.The prediction results of the online database TargetScan showed that E2F transcription factor 5(E2F5)had a potential target for binding to miR-20a-5p.The luciferase reporter gene assay confirmed that the target gene of miR-20a-5p was E2F5.Western blotting was used to detect the Bax,Bcl-2,and E2F5 protein expression.Results The relative expression levels of miR-20a-5p in OS cell lines U-20S,143B,and Saos-2 were 1.94±0.35,1.05±0.13,and 0.35±0.06,respectively,which were significantly lower than those in the normal human osteoblast cell line hFOB1.19 of 3.89±0.53(all P<0.05).Over the culture time,the OD values of the three groups showed an increasing trend.At 24,48,and 72 h of culture,the OD values increased in the miR-20a-5p overexpression group,the negative control group,and the miR-20a-5p inhibitory expression group under the same culture time in turn,with statistically significant difference between any two groups(all P<0.05).In the miR-20a-5p overexpression group,the negative control group,and the miR-20a-5p inhibitory expression group,the apoptosis rates and the relative expression of Bax protein decreased in sequence,and the number of invasive cells and the relative expression of Bcl-2 and E2F5 proteins increased in sequence,with statistically significant difference between any two groups(all P<0.05).Conclusions The expression of miR-20a-5p is downregulated in OS cell lines.Overexpression of miR-20a-5p can inhibit OS cells’proliferation and invasion,and induce apoptosis.The mechanism may be related to the down-regulation of E2F5,Bcl-2 and up-regulation of Bax protein expression.
作者 郭会 方艳君 李翠娥 段祥林 GUO Hui;FANG Yanjun;LI Cuie;DUAN Xianglin(Department of Orthopedics,Union Wuhan Red Cross Hospital,Wuhan 430000,China)
出处 《山东医药》 CAS 2022年第11期42-46,共5页 Shandong Medical Journal
关键词 骨肉瘤 miR-20a-5p 细胞增殖 细胞凋亡 细胞侵袭 E2F5 osteosarcoma miR-20a-5p cell proliferation cell apoptosis invasion E2F5
  • 相关文献

参考文献1

二级参考文献22

  • 1Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
  • 2El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127:S27-S34.
  • 3Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
  • 4Kim TIM, Yim SH, Shin SH, Xu HD, Jung YC, Park CK, Choi JY, Park WS, Kwon MS, Fiegler H, Carter NP, Rhyu MG, Chung YJ. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 2008; 123:2808-2815.
  • 5Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009; 9:785-797.
  • 6Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 2002; 16:245-256.
  • 7Han S, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat 2003; 82:11-16.
  • 8Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, Hofstetter G, Muller-Holzner E, Marth C, Zeimet AG. Clinical relevance of E2F family members in ovarian cancer-an evaluation in a training set of 77 patients. Clin Cancer Res 2007; 13:144-151.
  • 9Eymin B, Gazzeri S, Brambilla C, Brambilla E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene 2001; 20:1678-1687.
  • 10Lee J, Park CK, Park JO, Lim T, Park YS, Lim HY, Lee I, Sohn TS, Noh JH, Heo JS, Kim S, Lim do H, Kim KM, Kang WK. Impact of E2F-1 expression on clinical outcome of gastric adepatients with adjuvant chemoradiation therapy Clin Cancer Res 2008; 14:82-88.

共引文献9

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部